This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Dr. Martens Future Growth
Future criteria checks 0/6
Dr. Martens is forecast to grow earnings and revenue by 3.1% and 5.4% per annum respectively while EPS is expected to grow by 4.5% per annum.
Key information
3.1%
Earnings growth rate
4.46%
EPS growth rate
Luxury earnings growth
0%
Revenue growth rate
5.4%
Future return on equity
n/a
Analyst coverage
Good
Last updated
12 Jun 2023
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
BMV:DOCS N - Analysts future estimates and past financials data (GBP Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
3/31/2026
1,213
137
123
225
7
3/31/2025
1,116
116
94
187
7
3/31/2024
1,038
105
129
225
7
3/31/2023
1,000
129
26
77
N/A
12/31/2022
979
153
65
108
N/A
9/30/2022
957
177
104
138
N/A
6/30/2022
933
179
132
161
N/A
3/31/2022
908
181
159
184
N/A
12/31/2021
867
118
129
151
N/A
9/30/2021
825
54
98
117
N/A
6/30/2021
799
44
120
138
N/A
3/31/2021
773
35
142
159
N/A
12/31/2020
747
61
156
175
N/A
9/30/2020
722
87
169
190
N/A
6/30/2020
697
81
134
156
N/A
3/31/2020
672
75
100
121
N/A
3/31/2019
454
17
39
56
N/A
3/31/2018
349
-6
30
46
N/A
3/31/2017
291
-11
26
34
N/A
3/31/2016
232
-12
N/A
26
N/A
3/31/2015
235
0
N/A
20
N/A
3/31/2014
164
-32
N/A
5
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DOCS N's forecast earnings growth (3.1% per year) is below the savings rate (7.6%).
Earnings vs Market: DOCS N's earnings (3.1% per year) are forecast to grow slower than the MX market (9.2% per year).
High Growth Earnings: DOCS N's earnings are forecast to grow, but not significantly.
Revenue vs Market: DOCS N's revenue (5.4% per year) is forecast to grow slower than the MX market (6.2% per year).
High Growth Revenue: DOCS N's revenue (5.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DOCS N's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2023/06/14 10:55
End of Day Share Price
2023/03/17 00:00
Earnings
2023/03/31
Annual Earnings
2023/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dr. Martens plc is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.